People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Other Health Care, Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novel Microdevices, Inc. | — | Other Health Care | Seed | $4.2M | $2.0M | 2021 |
| Vixiar Medical, Inc. | — | Healthtech | Seed | $1.7M | $43.8M | 2013 |
| Osteovantage, Inc. | — | Other | Pre-Seed | $125K | $2.9M | 2013 |
Robert Storey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Storey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Calvin Goforth | 1 | 25 |
| Mark Calvin Kidd | 1 | 10 |
| Calvin Goforth | 1 | 10 |
| R. CALVIN GOFORTH | 1 | 10 |
| Mark Kidd | 1 | 5 |
| Omid Moghadam | 1 | 5 |
| Amit Mehta | 1 | 4 |
| Andrea Pais | 1 | 1 |
| Deborah Hemingway | 1 | 1 |
| Steve Yannaras | 1 | 1 |
| Michael Niggel | 1 | 1 |
| Kevin Thibodeau | 1 | 1 |
| Bob Calvin Storey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.